5 Key Takeaways

• 1

  Optometrists must utilize the latest AMD diagnostics for accurate early diagnosis, patient education, and monitoring disease progression.

• 2

  AI tools enhance AMD detection by identifying subtle disease signs and providing real-time risk stratification for better clinical decisions.

• 3

  Contrast sensitivity measurement is crucial for assessing visual function related to daily activities, especially in AMD patients.

• 4

  Dark adaptometry serves as an early biomarker for AMD, measuring the retina's recovery sensitivity in low light after bright exposure.

• 5

  Genetic testing can identify individuals at higher risk for AMD, aiding in personalized care and potential eligibility for clinical trials.